Nicole Lambert
Net worth: 1 M $ as of 31/05/2026
Net worth: 1 M $ as of 31/05/2026
Ms. Nicole Lambert is an Independent Director at Arcus Biosciences, Inc. and a President at Myriad Genetic Laboratories, Inc. She is on the Board of Directors at Arcus Biosciences, Inc. Ms. Lambert was previously employed as a Chief Operating Officer by Myriad Genetics, Inc. She received her undergraduate degree from Boston College and a graduate degree from Icahn School of Medicine at Mount Sinai.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 11/06/2026 | 43,000 ( 0.03% ) | 1 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| ARCUS BIOSCIENCES, INC. | Director/Board Member | 03/08/2021 |
Myriad Genetic Laboratories, Inc.
Myriad Genetic Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Provides cancer predisposition testing services | President | - |
| Companies | Position | End |
|---|---|---|
| MYRIAD GENETICS, INC. | Chief Operating Officer | 31/10/2023 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Myriad Genetics, Inc.
Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Myriad Genetic Laboratories, Inc.
Myriad Genetic Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Provides cancer predisposition testing services | Commercial Services |
Arcus Biosciences, Inc.
Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Select your edition
All financial news and data tailored to specific country editions